Skip to main content
. Author manuscript; available in PMC: 2013 Sep 11.
Published in final edited form as: J Clin Pharmacol. 2010 Apr 23;51(3):309–320. doi: 10.1177/0091270010368542

Figure 1.

Figure 1

Individual mycophenolic acid (MPA) concentration-time profiles at the 3 sampling days following oral administration are shown in the separate panels: (A) early posttransplant (n = 27), (B) prior to discharge (n = 25), and (C) at stable mycophenolate mofetil (MMF) treatment (n = 19). Individual MPA concentration-time profiles at the 3 sampling days following oral administration are shown in the separate panels A, B, and C. A tendency of reduced complexity and increased concentrations is observed over time after transplantation.